Press Release
COVID-19: Update from PharPoint Research
COVID-19: Update from PharPoint Research As the situation with COVID-19 evolves, the PharPoint Research team is taking necessary precautions to ensure study operations continue uninterrupted. During this critical time in our industry, PharPoint remains fully dedicated, as always, to helping clients improve global health. Our leadership team has been closely monitoring the situation since the...
March 16, 2020
No Comments
PharPoint expands European capabilities
RESEARCH TRIANGLE PARK, N.C. (June 1, 2016) — PharPoint Research, a U.S.-based contract research organization (CRO), today announced the expansion of their clinical trial management and consulting service capabilities into Europe. The extension provides PharPoint Research’s global drug development clients greater access to increasingly meaningful markets and increases their reach across the European continent. With rising…
October 9, 2019
No Comments
PharPoint incorporates EDC software Medrio into data management offerings
PharPoint Research, Inc., a drug development service company providing biostatistics and data management services to the pharmaceutical and biotechnology industries, announces that it has incorporated Medrio’s EDC technology platform into its growing suite of data management applications. “The addition of Medrio’s EDC solution to our existing offerings further supports PharPoint’s ability to consistently exceed our…
October 9, 2019
No Comments
PharPoint joins Medidata Solutions’ CRO partner program
Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, announced that PharPoint Research, Inc., a North Carolina-based drug development service company, has joined Medidata’s ASPire to Win® channel partner program, bringing the program’s partner count to 30 organizations. With this partnership, PharPoint will be able to offer the Medidata Rave® electronic data capture (EDC) and clinical data…
October 9, 2019
No Comments